MIMS Must Have's
A review of some of the most important safety related changes, new indications and formulations changes we have made to the MIMS Product Information this month.

Click on below to access: 

• Important New Products
  • Vyvanse
  • Xiaflex
• New Indications
• New Contraindications

Full Updated Medications

• Click here to read the
  Full Prescribing Update

Latest News

myDr
Hiccups: why do we hiccup?...more

Contraception: long-term options for women...more

Nuts in a healthy diet...more

Heartbeat...more

Consumer health and medical news and information from MIMS. Providing quality Australian patient information you can trust. myDr.com.au

Medical Observer
Cocoa could have stave off cognitive decline...more

Alarming diabetes rate revealed...more

GPs debate new diabetes drug...more

Training may improve insulin initiation...more

For regular medical news, features and lifestyle content sign-up to receive Medical Observer’s e-newsletter at: medicalobserver.com.au

From the Desk of the Managing Editor

Glucosamine concerns flagged by medicines hotline

The arthritis treatment glucosamine is among the three most asked-about complementary medicines, an analysis of a national medicines hotline has shown....more

iMIMS on iOS7 - Issues and Solutions
As many of you already know, Apple launched iOS7 on 19 Sep 2013.  iMIMS has not changed, however there are a couple of important issues that you need to be aware of.

MIMS will be releasing an App update soon but in the meantime, please read this article to ensure that you are able to continue using iMIMS.

eMIMS video on YouTube
Including much more information than the first eMIMS of 17 years ago, and with the ability to find it faster than ever, New eMIMS has been developed to meet the needs of our current users. Click here to watch the YouTube Video!